Salisbury Foundation Trust

FOI_5923

Internal Reference Number: FOI_5923

Date Request Received: 20/11/2020 10:06:45

Date Request Replied To: 13/01/2021 14:21:12

This response was sent via: By Email

Request Summary: prescribing in growth hormone & acromegaly

Request Category: Researcher

 
Question Number 1:
How many patients has your trust treated in the last 12 months with the following drugs?
• Octreotide
• Lanreotide
• Pasireotide
• Pegvisomant
• Genotropin
• Humatrope
• Norditropin
• Nutropin
• Omnitrope
• Saizen
• Zomacton
 
Answer To Question 1:
Please see attached refusal notice explaining why the Trust is unable to answer this FOI.
 
Question Number 2:
Please provide the number of patients under the age 16 that were treated in the last 12 months with each of the following drugs:
• Genotropin
• Humatrope
• Norditropin
• Nutropin
• Omnitrope
• Saizen
• Zomacton
 
Answer To Question 2:
Please see answer to Question 1.
 
Question Number 3:
How many patients have been treated in the last 12 months with the following drugs for Acromegaly (ICD10 code E22.0) ONLY?
• Sandostatin LAR
• Octreotide Long-Acting (Generic)
• Somatuline Autogel
• Pasireotide
 
Answer To Question 3:
Please see answer to Question 1.
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2021 Salisbury NHS Foundation Trust
Trust Values